NishaSaraJosephMD

PubMed

• Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience.
  Scott, S., Marin, E., Maples, K., Joseph, N., Hofmeister, C., Gupta, V., Kaufman, J., Lonial, S., Nooka, A., Dhodapkar, M.> ;Blood Cancer Journal. 2023 Dec 20
• Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity.
  Alberto Moreno, Kelly Manning, Maryam I Azeem, Ajay K Nooka, Madison Ellis, Renee Julia Manalo, Jeffrey M Switchenko, Bushra Wali, Jonathan L Kaufman, Craig C Hofmeist...> ;Research Square. 2023 Sep 21
• 3 citations
  Impact of Black Race on Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma Receiving Bortezomib Induction.
  Laura F Sun, Kathryn T Maples, Kevin H Hall, Yuan Liu, Yichun Cao, Nisha S Joseph, Craig C Hofmeister, Jonathan L Kaufman, Ajay K Nooka, Sagar Lonial, R Donald Harvey,...> ;JCO Oncology Practice. 2023 Sep 1
• 1 citations
  Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience.
  Kathryn T Maples, Kevin H Hall, Nisha S Joseph, Craig C Hofmeister, Vikas Gupta, Jonathan L Kaufman, Ajay K Nooka, Sagar Lonial, Dhodapkar, M.> ;Blood Cancer Journal. 2023 Feb 20
• Passenger pathogens on physicians.
  Christopher Ronald Funk, Sruthi Ravindranathan, Alex Matelski, Caitlin Taylor, Sanjay Chandrasekaran, Martha Arellano, Amelia A Langston, Nisha Joseph, Edmund K Waller...> ;American Journal of Infection Control. 2023 Jul 1
• 28 citations
  Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma.
  Nooka, A., Shanmugasundaram, U., Cheedarla, N., Verkerke, H., Edara, V., Valanparambil, R., Kaufman, J., Hofmeister, C., Joseph, N., Lonial, S., Azeem, M., Manalo, J.,...> ;Journal of Clinical Oncology. 2022 Sep 10
• 2 citations
  Venetoclax ex vivo functional profiling predicts improved progression-free survival.
  Gupta, V., Matulis, S., Barwick, B., Bog, R., Shebelut, C., Shanmugam, M., Neri, P., Bahlis, N., Dhodapkar, M., Heffner, L., Hofmeister, C., Joseph, N., Lonial, S., Ka...> ;Blood Cancer Journal. 2022 Aug 4
• 1 citations
  Impact of concurrent gabapentin or pregabalin with high-dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant.
  Akhilesh Sivakumar, Evan B Bryson, Kevin H Hall, Kathryn T Maples, Subir Goyal, Nisha S Joseph, Craig C Hofmeister, Jonathan L Kaufman, Sagar Lonial, Ajay K Nooka, Rob...> ;Pharmacotherapy. 2022 Mar 1
• 4 citations
  Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life.
  Nisha Joseph, Vikas Gupta, Sarah Wyman, Michael Graiser, Jonathan L. Kaufman, Dhwani Almaula, Joel Andrews, Craig C. Hofmeister, Leonard T. Heffner, Sagar Lonial, Ajay...> ;Transplantation and Cellular Therapy. 2021 Oct 6
• 13 citations
  Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia.
  , , , , , , , , , , , , , , , > ;Blood Cancer Discovery. 2021 Sep 1
• 7 citations
  Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor.
  Nisha Joseph, Yu-Tzu Tai, Kenneth C. Anderson, Sagar Lonial> ;Clinical Pharmacology. 2021 Aug 18
• 2 citations
  "I took the road less traveled, and that has made all the difference": Making a case for high-dose therapy and autologous stem cell transplantation in elderly patients...
  Ajay K. Nooka, Nisha Joseph, Sagar Lonial> ;Cancer. 2021 Nov 15
• Maintenance Strategies for Myeloma: Is Bigger Always Better?
  Ajay K. Nooka, Nisha Joseph> ;Cancer Journal. 2021 May 1
• 6 citations
  Natural history of multiple myeloma patients refractory to venetoclax: A single center experience
  Kathryn T Maples, Ajay K. Nooka, Vikas Gupta, Nisha Joseph, Leonard T. Heffner, Craig C. Hofmeister, Shannon M. Matulis, Sagar Lonial, Lawrence H. Boise, Jonathan L. K...> ;American Journal of Hematology. 2021 Mar 1
• 35 citations
  Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression.
  Vikas Gupta, Benjamin G. Barwick, Shannon M. Matulis, Ryosuke Shirasaki, David L. Jaye, Jonathan J Keats, Benjamin Oberlton, Nisha Joseph, Craig C. Hofmeister, Leonard...> ;Blood. 2021 Jul 1
• 22 citations
  Game of Bones: How Myeloma Manipulates Its Microenvironment.
  Tyler Moser-Katz, Nisha Joseph, Kelvin P. Lee, Lawrence H. Boise> ;Frontiers in Oncology. 2021 Feb 9
• Practical approach to the management of smoldering myeloma.
  Nisha Joseph, Sagar Lonial> ;Current Opinion in Oncology. 2020 Nov 1
• 8 citations
  Current developments in the combination therapy of relapsed/refractory multiple myeloma
  Kathryn T Maples, Nisha Joseph, R. Donald Harvey> ;Expert Review of Anticancer Therapy. 2020 Oct 7
• 124 citations
  Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma
  Nisha Joseph, Jonathan L. Kaufman, Craig C. Hofmeister, Dhwani Almaula, Leonard T. Heffner, Vikas Gupta, Lawrence H. Boise, Sagar Lonial, Ajay K. Nooka> ;Journal of Clinical Oncology. 2020 Apr 16
• 17 citations
  Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
  Roberto Mina, Nisha Joseph, Efstathios Kastritis, Maria Teresa Petrucci, Jonathan L. Kaufman, Vittorio Montefusco, Maria Gavriatopoulou, Francesca Patriarca, Paola Ome...> ;Blood Cancer Journal. 2020 Apr 14
• 12 citations
  The Role of Early Intervention in High-Risk Smoldering Myeloma.
  Nisha Joseph, Sagar Lonial> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2020 Mar 17
• 2 citations
  Approaches to Treating Multiple Myeloma, Now and Moving Forward.
  Vikas Gupta, Nisha Joseph, Ajay K. Nooka> ;JCO Oncology Practice. 2020 Jan 10
• 104 citations
  Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone.
  Timothy M. Schmidt, Benjamin G. Barwick, Nisha Joseph, Leonard T. Heffner, Craig C. Hofmeister, Leon Bernal, Vikas Gupta, David L. Jaye, Jiayi Wu, Subir Goyal, Zhengji...> ;Blood Cancer Journal. 2019 Nov 25
• 65 citations
  Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refra...
  Ajay K. Nooka, Nisha Joseph, Jonathan L. Kaufman, Leonard T. Heffner, Vikas Gupta, Charise Gleason, Lawrence H. Boise, Sagar Lonial> ;Cancer. 2019 Sep 1
• 85 citations
  Daratumumab in multiple myeloma.
  Ajay K. Nooka, Jonathan L. Kaufman, Craig C. Hofmeister, Nisha Joseph, Thomas L. Heffner, Vikas Gupta, Harold C. Sullivan, Andrew S. Neish, Sagar Lonial> ;Cancer. 2019 Jul 15
• Join now to see all

Abstracts/Posters

• Outcomes of Elderly Patients Undergoing Allogeneic Transplantation for Acute Myeloid Leukemia with Fludarabine/Melphalan or Fludarabine/TBI Conditioning Regimen
  Nisha Joseph, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Outcomes of Myeloma Patients with Deletion 1p Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Therapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018